Publication:
Cryptosporidiosis: A Rare and Severe Infection in a Pediatric Renal Transplant Recipient

dc.authorscopusid18036882700
dc.authorscopusid7003365098
dc.authorscopusid10642354300
dc.authorscopusid19933498800
dc.authorscopusid32467523200
dc.authorscopusid6602745102
dc.contributor.authorAçıkgöz, Y.
dc.contributor.authorÖzkaya, O.
dc.contributor.authorBek, K.
dc.contributor.authorGenç, G.
dc.contributor.authorŞensoy, S.G.
dc.contributor.authorHökelek, M.
dc.date.accessioned2020-06-21T14:27:44Z
dc.date.available2020-06-21T14:27:44Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Açıkgöz] Yonca, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özkaya] Ozan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bek] Kenan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Genç] Gürkan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şensoy] Gülnar, Department of Pediatric Infection, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Hökelek] Murat, Department of Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractCryptosporidium is an intracellular protozoan parasite that causes gastroenteritis in human. In immunocompromised individuals, cryptosporidium causes far more serious disease. There is no effective specific therapy for cryptosporidiosis, and spontaneous recovery is the rule in healthy individuals. However, immunocompromised patients need effective and prolonged therapy. Here, we present our clinical experience in a six-yr-old boy who underwent living-related donor renal transplantation and who was infected with Cryptosporidium spp. Our patient was successfully treated with antimicrobial agents consisting of spiramycin, nitazoxanide, and paromomycin. At the end of second week of therapy, his stool became negative for Cryptosporidium spp. antigen and spiramycin was discontinued. Nitazoxanide and paromomycin treatment was extended to four wk. With this case, we want to emphasize that cryptosporidiosis should be considered in the differential diagnosis of severe or persistent diarrhea in solid organ transplant recipients where rigorous antimicrobial therapy is needed. © 2011 John Wiley & Sons A/S.en_US
dc.identifier.doi10.1111/j.1399-3046.2011.01473.x
dc.identifier.endpageE119en_US
dc.identifier.issn1397-3142
dc.identifier.issn1399-3046
dc.identifier.issue4en_US
dc.identifier.pmid21320246
dc.identifier.scopus2-s2.0-84861190021
dc.identifier.scopusqualityQ2
dc.identifier.startpageE115en_US
dc.identifier.urihttps://doi.org/10.1111/j.1399-3046.2011.01473.x
dc.identifier.volume16en_US
dc.identifier.wosWOS:000303998800004
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofPediatric Transplantationen_US
dc.relation.journalPediatric Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCryptosporidiumen_US
dc.subjectPediatricsen_US
dc.subjectRenal Transplanten_US
dc.titleCryptosporidiosis: A Rare and Severe Infection in a Pediatric Renal Transplant Recipienten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files